The 10-point policy gap score

1. Mentions prescription medication at all — and medicinal cannabis specifically.
2. States whether the standard is detection above a cut-off or impairment (vague hybrids lose cases both ways).
3. Requires disclosure of medication that could affect safe performance — and says to whom and when.
4. Frames disclosure as an ongoing duty covering changed prescriptions and resumed use (the Haigh clause).
5. Says what happens after disclosure: assessment, medical input, possible adjusted duties — not straight to discipline.
6. Names the testing standards used (AS/NZS 4760:2019 oral fluid, AS/NZS 4308 urine, AS 3547 breath) and matches the kits actually on site (the Parks trap).
7. Guarantees confirmatory laboratory testing before any disciplinary decision.
8. Explains how medical information is stored, who can see it, and how privacy is protected.
9. Was consulted with the workforce, with a record kept, as WHS law expects.
10. Has been reviewed since medicinal cannabis prescribing became mainstream — effectively, since 2020.

Score this policy